ARTIVA BIOTHERAPEUTICS INC (ARTV) Stock Balance Sheet
USA - NASDAQ:ARTV - US04317A1079 - Common Stock
3.94 USD
-0.45 (-10.25%)
4.04 USD
+0.1 (+2.54%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | N/A | 40.23M | 53.50M | 102.53M | 160.92M | |||
| Marketable Securities | 113.90M | 145.19M | 23.47M | 0.00 | N/A | |||
| Receivables | 30.00K | 146.00K | 1.76M | 525.00K | 468.00K | |||
| Other Current Assets | 6.67M | 3.06M | 1.09M | 1.62M | 896.00K | |||
| Total Current Assets | 149.07M | 188.63M | 79.82M | 104.67M | 162.29M | |||
| Non-Current Assets | ||||||||
| PPE Net | 19.83M | 20.43M | 24.64M | 27.62M | 4.08M | |||
| Other Non-Current Assets | 499.00K | 525.00K | 650.00K | 762.00K | 3.56M | |||
| Total Non-Current Assets | 20.32M | 20.95M | 25.29M | 28.38M | 7.64M | |||
| TOTAL ASSETS | 169.39M | 209.58M | 105.11M | 133.05M | 169.93M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 106.00K | 122.00K | N/A | N/A | N/A | |||
| Accrued Expenses | 9.37M | 11.01M | 11.61M | 13.64M | 10.57M | |||
| Accounts Payable | 1.22M | 1.12M | 614.00K | 1.10M | 1.44M | |||
| Other Current Liabilities | 73.00K | N/A | 0.00 | 10.89M | 7.29M | |||
| Total Current Liabilities | 10.77M | 12.25M | 12.23M | 25.63M | 19.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 44.00K | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 9.58M | 10.64M | 38.49M | 31.71M | 23.07M | |||
| Total Non-Current Liabilities | 9.58M | 10.69M | 38.49M | 31.71M | 23.07M | |||
| TOTAL LIABILITIES | 20.35M | 22.94M | 50.72M | 57.34M | 42.37M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -288.25M | -246.68M | -181.31M | -152.59M | -93.80M | |||
| Additional Paid In Capital | 437.29M | 433.45M | 18.99M | 11.89M | 4.95M | |||
| Common Shares | 3.00K | 3.00K | 216.41M | 216.41M | 216.41M | |||
| Other Shareholders' Equity | 2.00K | -129.00K | 308.00K | 0.00 | N/A | |||
| Shares Outstanding | 24.39M | 24.29M | 23.28M | 23.28M | 23.28M | |||
| Tangible Book Value per Share | 6.11 | 7.68 | -6.96 | -6.04 | -3.82 | |||
| Total Shareholders' Equity | 149.04M | 186.64M | 54.40M | 75.72M | 127.56M | |||
| TOTAL LIABILITIES AND EQUITY | 169.39M | 209.58M | 105.11M | 133.05M | 169.93M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | N/A | N/A | N/A | |||
| Current Ratio | 13.84 | 15.39 | 6.53 | 4.08 | 8.41 | |||
| Return On Assets (ROA) | -44.08% | -31.19% | -27.32% | -44.18% | -42.27% | |||
| Return On Equity (ROE) | -50.09% | -35.03% | -52.80% | -77.64% | -56.31% | |||
All data in USD , ROIC based on taxRate of 0.21